ドラッグデリバリー市場：経口ドラッグデリバリー、デバイスタイプ、流通チャネル、用途別-2025～2030年世界予測

ドラッグデリバリー市場は、2023年に17億2,000万米ドルと評価され、2024年には18億2,000万米ドルに達すると予測され、CAGR 6.41％で成長し、2030年には26億5,000万米ドルになると予測されています。

ドラッグデリバリー市場には、特定の結果を得るために治療物質を制御された方法で投与することを目的としたさまざまな技術が含まれます。これは、薬効、患者のコンプライアンス、安全性を向上させるために極めて重要です。ドラッグデリバリーシステムには、錠剤や注射のような伝統的媒体に加え、ナノ粒子、リポソーム、ハイドロゲルのような先進的手法が含まれます。革新的なドラッグデリバリーシステムの必要性は、正確なターゲティングとコントロールされたリリースを必要とする生物製剤や個別化医療を含む医薬品の複雑化に起因しています。用途は製薬、バイオテクノロジー、病院、クリニックなど多岐にわたり、最終用途のシナリオは慢性疾患管理、がん治療、ワクチン送達、診断に重点が置かれています。

同市場は、慢性疾患の有病率の上昇、技術の進歩、研究開発投資の増加といった要因に大きく影響されています。IoTやAIのようなスマート技術の統合により、精度とモニタリング能力をさらに高めるインテリジェントな送達システムを構築する機会が生まれています。バイオセンサーとバイオアベイラビリティ・ブースターは、開発の有望な道筋を示しています。こうした機会を活用するため、企業はハイテク企業や研究機関との共同パートナーシップに注力し、次世代送達プラットフォームの革新に取り組むべきです。

しかし、市場は厳しい規制の枠組みや先進的送達システムの開発コストの高さによる制約に直面しており、これが中小企業の足かせとなっています。さらに、専門知識の必要性や、新興技術を既存の枠組みに統合することの複雑さといった課題も、大きなハードルとなっています。このような状況にもかかわらず、イノベーションの機が熟しているセグメントには、非侵襲的な送達方法の開発や、個々の患者のプロファイルに合わせた個別化ドラッグデリバリーシステムなどがあり、採用率を大幅に高めることができます。市場力学と消費者ニーズを理解することは、企業が移り変わる情勢をうまく乗り切るために不可欠です。ドラッグデリバリー市場は、急速な技術革新のペースと高い投資ポテンシャルを特徴としており、効率的で効果的な治療ソリューションに対する需要の高まりに対応するため、規制面や技術面での課題を克服できる企業には、幅広いビジネス機会がもたらされます。

市場力学：急速に進化するドラッグデリバリー市場の主要市場洞察を公開

ドラッグデリバリー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の生物製剤の使用増加
  • 効果的なドラッグデリバリーメカニズムへの需要の高まり
  • 慢性疾患の大幅な増加
• 市場抑制要因
  • 医薬品の回収と失敗の増加
  • 薬剤に伴う副作用とリスク
• 市場機会
  • 費用対効果の高い医療治療への需要の高まり
  • 在宅ケアと自己投与への関心の高まり
• 市場課題
  • 価格圧力と特許切れ問題

ポーターのファイブフォース：ドラッグデリバリー市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ドラッグデリバリー市場における外部からの影響の把握

外部マクロ環境要因は、ドラッグデリバリー市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ドラッグデリバリー市場における競合情勢の把握

ドラッグデリバリー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ドラッグデリバリー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ドラッグデリバリー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ドラッグデリバリー市場における成功への道筋を描く

ドラッグデリバリー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で生物学的医薬品の使用が増加
    • 効果的なドラッグデリバリーメカニズムに対する需要の高まり
    • 慢性疾患の大幅な増加
  • 抑制要因
    • 医薬品の回収と欠陥の増加
    • 薬に伴う副作用とリスク
  • 機会
    • 費用対効果の高い医療治療に対する需要の高まり
    • 在宅ケアと自己管理への注目の高まり
  • 課題
    • 価格圧力と特許切れの問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ドラッグデリバリー市場：経口ドラッグデリバリー別

• イントロダクション
• 注射ドラッグデリバリー
• 経鼻ドラッグデリバリー
• 眼球ドラッグデリバリー
• 経肺ドラッグデリバリー
• 局所ドラッグデリバリー

第7章 ドラッグデリバリー市場：デバイスタイプ別

• イントロダクション
• 先進型
• 従来型

第8章 ドラッグデリバリー市場：流通チャネル別

• イントロダクション
• 病院薬局
• 小売薬局

第9章 ドラッグデリバリー市場：用途別

• イントロダクション
• がん
• 心血管疾患
• 糖尿病
• 呼吸器疾患

第10章 南北アメリカのドラッグデリバリー市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のドラッグデリバリー市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのドラッグデリバリー市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company
• Enable Injections, Inc.
• Gerresheimer AG
• Johnson & Johnson Services Inc.
• Kindeva Drug Delivery
• Koninklijke Philips N.V.
• Merck KGaA
• Novartis AG
• nsulet Corporation
• OraSure Technologies, Inc.
• Oxford BioMedica PLC
• Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. DRUG DELIVERY MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DELIVERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DELIVERY MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY PULMONARY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADVANCED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 38. CANADA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 60. CHINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 62. CHINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 64. INDIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 66. INDIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 133. ITALY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 135. ITALY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 149. POLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 151. POLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 153. QATAR DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 155. QATAR DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Delivery Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.82 billion in 2024, and is projected to grow at a CAGR of 6.41%, to USD 2.65 billion by 2030.

The drug delivery market encompasses a range of technologies aimed at administering therapeutic substances in a controlled manner to achieve specific outcomes. This is crucial for improving drug efficacy, patient compliance, and safety. Drug delivery systems can include advanced methodologies like nanoparticles, liposomes, and hydrogels, alongside traditional mediums such as tablets and injections. The necessity of innovative drug delivery systems stems from the increasing complexity of pharmaceuticals, including biologics and personalized medicine, which require precise targeting and controlled release. Applications span across pharmaceuticals, biotechnology, hospitals, and clinics, with end-use scenarios focusing on chronic disease management, cancer therapy, vaccine delivery, and diagnostics.

The market is significantly influenced by factors such as the rising prevalence of chronic diseases, technological advancements, and increased investment in R&D. Opportunities are emerging through the integration of smart technologies like IoT and AI to create intelligent delivery systems that further enhance precision and monitoring capabilities. Biosensors and bioavailability boosters present promising avenues for development. To capitalize on these opportunities, companies should focus on collaborative partnerships with tech firms and research institutions to innovate next-generation delivery platforms.

However, the market faces limitations from stringent regulatory frameworks and the high cost of developing advanced delivery systems, which can impede smaller companies. Moreover, challenges such as the need for specialized knowledge and the complexity of integrating emerging technologies into existing frameworks also pose significant hurdles. Despite these, areas ripe for innovation include the development of non-invasive delivery methods and personalized drug delivery systems tailored to individual patient profiles, which can significantly enhance adoption rates. Understanding market dynamics and consumer needs will be critical for companies to navigate the shifting landscape successfully. The drug delivery market, characterized by its rapid innovation pace and high investment potential, offers broad opportunities for companies that can overcome regulatory and technological challenges to meet growing demand for efficient and effective treatment solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Market

The Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use of biological drugs worldwide
  • Swelling demand for effective drug delivery mechanisms
  • Significant increase in chronic diseases
• Market Restraints
  • Increasing drug recalls and drug failures
  • Side effects and risk associated with the drugs
• Market Opportunities
  • Rising demand for cost-effective healthcare treatment
  • Growing focus towards home care and self-administration
• Market Challenges
  • Pricing pressure and issues with patents expiry

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Market

A detailed market share analysis in the Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Market

A strategic analysis of the Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Antares Pharma, Inc. by Halozyme Therapeutics, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Enable Injections, Inc., Gerresheimer AG, Johnson & Johnson Services Inc., Kindeva Drug Delivery, Koninklijke Philips N.V., Merck KGaA, Novartis AG, nsulet Corporation, OraSure Technologies, Inc., Oxford BioMedica PLC, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Oral Drug Delivery, market is studied across Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, and Topical Drug Delivery.
• Based on Device Type, market is studied across Advanced and Conventional.
• Based on Distribution Channels, market is studied across Hospital Pharmacies and Retail Pharmacies.
• Based on Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use of biological drugs worldwide
    • 5.1.1.2. Swelling demand for effective drug delivery mechanisms
    • 5.1.1.3. Significant increase in chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Increasing drug recalls and drug failures
    • 5.1.2.2. Side effects and risk associated with the drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising demand for cost-effective healthcare treatment
    • 5.1.3.2. Growing focus towards home care and self-administration
  • 5.1.4. Challenges
    • 5.1.4.1. Pricing pressure and issues with patents expiry
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Delivery Market, by Oral Drug Delivery

• 6.1. Introduction
• 6.2. Injectable Drug Delivery
• 6.3. Nasal Drug Delivery
• 6.4. Ocular Drug Delivery
• 6.5. Pulmonary Drug Delivery
• 6.6. Topical Drug Delivery

7. Drug Delivery Market, by Device Type

• 7.1. Introduction
• 7.2. Advanced
• 7.3. Conventional

8. Drug Delivery Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Retail Pharmacies

9. Drug Delivery Market, by Application

• 9.1. Introduction
• 9.2. Cancer
• 9.3. Cardiovascular Diseases
• 9.4. Diabetes
• 9.5. Respiratory Diseases

10. Americas Drug Delivery Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Drug Delivery Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
• 2. B. Braun SE
• 3. Baxter International Inc.
• 4. Becton, Dickinson and Company
• 5. Enable Injections, Inc.
• 6. Gerresheimer AG
• 7. Johnson & Johnson Services Inc.
• 8. Kindeva Drug Delivery
• 9. Koninklijke Philips N.V.
• 10. Merck KGaA
• 11. Novartis AG
• 12. nsulet Corporation
• 13. OraSure Technologies, Inc.
• 14. Oxford BioMedica PLC
• 15. Sanofi S.A.